NSG 233 MED SURG 1 EXAM 2026 EXAM Q&A
STUDY GUIDE COMPLETE QUESTIONS WITH
VERIFIED SOLUTIONS
◉ Incentive Spirometry. Answer: Promotes deep breathing and lung
expansion.
◉ Patient Controlled Analgesia (PCA). Answer: Allows patients to
manage their own pain.
◉ Opioid-Tolerant. Answer: Patient on 60 mg morphine for a week.
◉ Opioid-Naive. Answer: Patient without prior narcotic exposure.
◉ Pain Assessment Tool. Answer: Use 0-10 scale for consistent pain
evaluation.
◉ Sedation Assessment. Answer: Evaluate sedation levels using
standardized tools.
◉ Respiratory Assessment. Answer: Check rate, quality, and oxygen
saturation.
,◉ Esophageal Cancer. Answer: Includes adenocarcinoma and
squamous cell carcinoma.
◉ Survival Rate. Answer: 90% if esophageal cancer is detected early.
◉ Dysphagia. Answer: Difficulty swallowing, progresses from solids
to liquids.
◉ Regurgitation. Answer: Undigested food returning to the throat,
late sign.
◉ Halitosis. Answer: Foul breath, often a late sign of cancer.
◉ CT & PET Scans. Answer: Imaging to check for metastasis in
cancer.
◉ Esophagogastroduodenoscopy (EGD). Answer: Gold standard for
viewing upper GI diseases.
◉ Clinical Manifestations. Answer: Signs and symptoms indicating
esophageal cancer.
, ◉ Tracheal Compression. Answer: Can cause respiratory distress in
advanced cancer.
◉ Painful Swallowing. Answer: Odynophagia, indicates potential
esophageal issues.
◉ Substernal Pain. Answer: Pain or fullness beneath the sternum.
◉ Hiccups. Answer: Late sign of esophageal obstruction or irritation.
◉ Complications Monitoring. Answer: Watch for potential issues in
chest tube patients.
◉ Fluid Volume Maintenance. Answer: Ensure adequate hydration
and nutrition for patients.
◉ Mobility Promotion. Answer: Encourage movement and shoulder
exercises post-surgery.
◉ Exploratory laparoscopy. Answer: Best method to locate positive
lymph nodes.
◉ Tissue biopsy. Answer: Official method for cancer diagnosis and
staging.
STUDY GUIDE COMPLETE QUESTIONS WITH
VERIFIED SOLUTIONS
◉ Incentive Spirometry. Answer: Promotes deep breathing and lung
expansion.
◉ Patient Controlled Analgesia (PCA). Answer: Allows patients to
manage their own pain.
◉ Opioid-Tolerant. Answer: Patient on 60 mg morphine for a week.
◉ Opioid-Naive. Answer: Patient without prior narcotic exposure.
◉ Pain Assessment Tool. Answer: Use 0-10 scale for consistent pain
evaluation.
◉ Sedation Assessment. Answer: Evaluate sedation levels using
standardized tools.
◉ Respiratory Assessment. Answer: Check rate, quality, and oxygen
saturation.
,◉ Esophageal Cancer. Answer: Includes adenocarcinoma and
squamous cell carcinoma.
◉ Survival Rate. Answer: 90% if esophageal cancer is detected early.
◉ Dysphagia. Answer: Difficulty swallowing, progresses from solids
to liquids.
◉ Regurgitation. Answer: Undigested food returning to the throat,
late sign.
◉ Halitosis. Answer: Foul breath, often a late sign of cancer.
◉ CT & PET Scans. Answer: Imaging to check for metastasis in
cancer.
◉ Esophagogastroduodenoscopy (EGD). Answer: Gold standard for
viewing upper GI diseases.
◉ Clinical Manifestations. Answer: Signs and symptoms indicating
esophageal cancer.
, ◉ Tracheal Compression. Answer: Can cause respiratory distress in
advanced cancer.
◉ Painful Swallowing. Answer: Odynophagia, indicates potential
esophageal issues.
◉ Substernal Pain. Answer: Pain or fullness beneath the sternum.
◉ Hiccups. Answer: Late sign of esophageal obstruction or irritation.
◉ Complications Monitoring. Answer: Watch for potential issues in
chest tube patients.
◉ Fluid Volume Maintenance. Answer: Ensure adequate hydration
and nutrition for patients.
◉ Mobility Promotion. Answer: Encourage movement and shoulder
exercises post-surgery.
◉ Exploratory laparoscopy. Answer: Best method to locate positive
lymph nodes.
◉ Tissue biopsy. Answer: Official method for cancer diagnosis and
staging.
